retatrutide mechanism triple agonist gip glp-1 glucagon receptor Frontiers Retatrutide Guide 2023: Weight Loss,
Description
Your body is meeting a powerful new signaling molecule, and the adjustment period involves real physiological changes that affect everything from appetite to energy levels to digestive function
doi: 10.1517/14656566.7.15.2095 [DOI] [PubMed] [Google Scholar] 143
Wegovy may be suitable for adults who have obesity or who are overweight and already have a weight-related comorbidity
Persistent gastrointestinal symptoms should prompt evaluation for other conditions, as these medications can unmask or worsen pre-existing digestive disorders
Monitor FDA.gov for updates
